Central Illinois Hematology Oncology Center — Springfield, Illinois

Central Illinois Hematology Oncology Center is a clinical research site located in Springfield, Illinois, United States 62702.

Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.

Central Illinois Hematology Oncology Center has participated in 136 clinical trials with 44 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), University of Chicago, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Springfield

Browse all research sites in Illinois · View every site in Springfield

• Southern Illinois University-Simmons
• Prairie Heart Institute / St. John's Hospital
• St. Elizabeth's Hospital of the Hospital Sisters of the Third Order of St. Francis
• St. John's Hospital - Prairie Cardiovascular Consultants
• Southern Illinois University of Medicine
• St. John's Hospital/Prarie Education and Research Cooperative
• Southern Illnois University School of Medicine
• Prairie Heart Institute at St. Johns Hospital
• St. John's Hospital
• Research Cooperative, St. John's Hospital
• Southern Illinois University Medical Center
• Southern Ilinois University School of Medicine

Sponsor Feasibility Report

Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Illinois Hematology Oncology Center?

Central Illinois Hematology Oncology Center has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Illinois Hematology Oncology Center conducted?

Central Illinois Hematology Oncology Center has 136 clinical trials on record, with 44 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Central Illinois Hematology Oncology Center accredited by Crixeo Clinical Trials?

Central Illinois Hematology Oncology Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Illinois Hematology Oncology Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.